ArticleVaccines2022

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants.

Ruiqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.